Literature DB >> 15465117

Regulation of bile acid synthesis under reconstructed enterohepatic circulation in rats.

Masahiro Nagano1, Syoji Kuroki, Atsushi Mizuta, Masae Furukawa, Mitsuhide Noshiro, Kazuo Chijiiwa, Masao Tanaka.   

Abstract

Cholesterol 7alpha-hydroxylase (CYP7A1) is regulated by bile acids through the farnesoid X receptor (FXR) mechanism in a negative feedback fashion. However, the fact that CYP7A1 is down-regulated by intraduodenal administration of bile acid, but not by intravenous administration may not be explained only by this mechanism. The aim of this study was to establish a new rat model with reconstructed or simulated enterohepatic circulation to examine if intravenous or portal administration of bile acid can regulate CYP7A1. Under biliary drainage, taurocholate (0 or 6 micromol/h/100g body weight) was administered continuously for 48h into the duodenum (ID-0/ID-6), femoral vein (IV-0/IV-6), or portal vein (IP-0/IP-6) to create a condition in which biliary bile acids were continuously lost, and a similar dose of taurocholate was supplied to the liver simultaneously. CYP7A1 activity and mRNA expression of the ID-0 group were significantly increased compared with the no treatment (NT) group. CYP7A1 activity and mRNA expression of the ID-6 group were suppressed significantly to 41 and 46% of those of the ID-0 group, respectively. In the IV-6 and IP-6 groups, however, enzyme activity and mRNA expression were decreased slightly, but the suppression was not statistically significant. The results suggested that portal as well as intravenous administration of bile acids cannot suppress bile acid synthesis as effectively as intraduodenal administration. It was concluded that an unidentified regulatory factor other than the nuclear receptors may be involved in bile acid synthesis in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15465117     DOI: 10.1016/j.steroids.2004.07.004

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  11 in total

Review 1.  Endocrine fibroblast growth factors 15/19 and 21: from feast to famine.

Authors:  Matthew J Potthoff; Steven A Kliewer; David J Mangelsdorf
Journal:  Genes Dev       Date:  2012-02-02       Impact factor: 11.361

Review 2.  Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23.

Authors:  Chiara Degirolamo; Carlo Sabbà; Antonio Moschetta
Journal:  Nat Rev Drug Discov       Date:  2015-11-16       Impact factor: 84.694

3.  Pectin Penta-Oligogalacturonide Suppresses Intestinal Bile Acids Absorption and Downregulates the FXR-FGF15 Axis in High-Cholesterol Fed Mice.

Authors:  Rugang Zhu; Yuting Hou; Yandi Sun; Tuoping Li; Jungang Fan; Gang Chen; Junxiu Wei
Journal:  Lipids       Date:  2017-05-04       Impact factor: 1.880

4.  FGF15/19 protein levels in the portal blood do not reflect changes in the ileal FGF15/19 or hepatic CYP7A1 mRNA levels.

Authors:  Quan Shang; Grace L Guo; Akira Honda; Monica Saumoy; Gerald Salen; Guorong Xu
Journal:  J Lipid Res       Date:  2013-07-12       Impact factor: 5.922

Review 5.  Nuclear-receptor-mediated regulation of drug- and bile-acid-transporter proteins in gut and liver.

Authors:  Jeff L Staudinger; Sarah Woody; Mengxi Sun; Wenqi Cui
Journal:  Drug Metab Rev       Date:  2013-02       Impact factor: 4.518

Review 6.  Intestinal bile acid physiology and pathophysiology.

Authors:  Olga Martinez-Augustin; Fermin Sanchez de Medina
Journal:  World J Gastroenterol       Date:  2008-10-07       Impact factor: 5.742

Review 7.  New Options in Constipation Management.

Authors:  Mellar Davis; Pamela Gamier
Journal:  Curr Oncol Rep       Date:  2015-12       Impact factor: 5.075

8.  Of mice and men: murine bile acids explain species differences in the regulation of bile acid and cholesterol metabolism.

Authors:  Sara Straniero; Amit Laskar; Christina Savva; Jennifer Härdfeldt; Bo Angelin; Mats Rudling
Journal:  J Lipid Res       Date:  2020-02-21       Impact factor: 5.922

Review 9.  Key discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decades.

Authors:  Alan F Hofmann; Lee R Hagey
Journal:  J Lipid Res       Date:  2014-05-17       Impact factor: 5.922

10.  Chronic diarrhea due to excessive bile acid synthesis and not defective ileal transport: a new syndrome of defective fibroblast growth factor 19 release.

Authors:  Alan F Hofmann; David J Mangelsdorf; Steven A Kliewer
Journal:  Clin Gastroenterol Hepatol       Date:  2009-08-07       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.